Popular Articles
Cellulite Treatment

New Jersey Senate, Assembly Panels Advance Autism Coverage Bill
Committees in the New Jersey Senate and Assembly on Monday unanimously approved a bill that would provide insurance benefits of up to $36,000 annually for autism treatments, the Philadelphia Inquirer reports. The funding, provided to developmentally disabled individuals younger than age 21, would go toward diagnostic services and early behavioral intervention, as well as occupational, physical and speech therapies. The Assembly could vote on the bill as early as Thursday, while the Senate bill is being considered by the state Senate Budget and Appropriations Committee.Sen. Loretta Weinberg (D), who sponsored the Senate bill, said, "I don"t know of any parent who wouldn"t do everything in their power to give their autistic or developmentally disabled child every chance to excel. However, the enormous cost of behavior intervention ... makes it out of the realm of possibility for many families." Assembly Speaker Joseph Roberts (D), who sponsored the Assembly bill, said, "In this economy, every New Jersey resident is struggling, but families with kids with special needs are struggling even more," adding, "They"re maxing out their credit cards and taking out second mortgages" to cover gaps in health insurance benefits.Citing cost issues, the New Jersey Business and Industry Association and the New Jersey Association of Health Plans were among those opposed to the bill. Christine Stearns, NJBIA vice president for health and legal affairs, said that the bill would make employer-sponsored insurance more costly and cause firms to drop such coverage, adding, "How, who and what is part of a basic health plan is all part of that." Stearns added that the bill is preferable to previous versions because it mandates that covered services be medically necessary and prescribed, places a reasonable cap on prices and ensures that the cost of educational services provided by schools is not shifted to insurers. Roberts said the bill would save money by delivering earlier treatment that could prevent more costly problems in the future (Henry, Philadelphia Inquirer, 5/19).
generic viagra online
Dr. David B. Samadi Introduces New Prostate Cancer Care Center For Robotic Surgery Patients At Mount Sinai Medical Center
The Mount Sinai Medical Center has a new re center for prostate cancer treatment. Led by David B. Samadi, M.D., Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology, the new state-of-the-art facility at 625 Madison Avenue in New York City specializes in pre- and post-surgery care for patients who undergo a robotic prostatectomy at Mount Sinai"s main campus. It also provides expertise in the treatment of other urologic cancers, including bladder and kidney. A multilingual staff offers assistance with patient travel arrangements, accommodations, and translation services when required.
News of the day
Mindblind Eyes: An Absence Of Spontaneous Theory Of Mind In Asperger Syndrome
Highly intelligent adults with Asperger Syndrome still have difficulties in day-to-day social interaction. These difficulties may be explained by "mindblindness", the idea that they are unable to predict what other people will do by thinking about their mental states, that is, their knowledge and beliefs. If this is true then why do people with Asperger syndrome pass all the standard tests of mental state attribution? Is the theory wrong or are the tests insensitive? This study reports evidence from eye movements, that adults with Asperger Syndrome do not spontaneously anticipate another person"s behaviour on the basis of that person"s mental state. This is in stark contrast with typical adults, and even young toddlers.
Diagnostics

Poster Submissions Invited For PAC - Pharmaceutical Society Of Australia

A major feature of the annual Pharmacy Australia Congress is the Poster Session which will attract a great deal of interest and provide unprecedented exposure for their authors. This year"s PAC will focus on the theme of Securing Your Practice Advantage and PAC organisers are inviting submissions for the Poster Displays at this year"s Congress to be held at the Sydney Hilton 15 - 18 October 2009. The Poster session at PAC will provide the opportunity for researchers and practitioners to share their research findings with attendees and members of the Pharmaceutical Society of Australia. Australians researchers lead the way in many aspects of pharmacy practice research and this is a fantastic opportunity for researchers to demonstrate their research and practice innovations. Delegates to the Congress include a wide range of pharmacy professionals, industry representatives, media and students so the poster work accented for display will be given invaluable exposure to a diverse and influential audience. The deadline for Abstract Submissions is 15 August 2009. The abstract should be a summary that does not exceed the 250 word limit (not including authors and affiliations). Those exceeding the word limit will be returned to the author for editing and risk missing the submission deadline. Abstracts will only be accepted by via the online submission process, should you encounter problems with this process please contact the Congress Secretariat. For full details and to download the submissions form go here. Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):